Fool - Investing News
06 Jun 2026, 18:19 UTC · 3h ago
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
Top 2 movers · tap to explore
Fool - Investing News
06 Jun 2026, 18:19 UTC · 3h ago
Top 2 movers · tap to explore
Story key points
3 claims · impact-rated
Twist Bioscience raised its 2026 full-year sales growth guidance to 17% to 19% year over year. — Upward revisions to annual revenue guidance typically signal strong fundamental growth and drive stock price appreciation.
+0.60Twist Bioscience reported fiscal second quarter revenue growth of 19% year over year to $110.7 million. — Strong double-digit revenue growth confirms the company's current growth trajectory and operational performance.
+0.40Chief Legal Officer Dennis Cho sold 14,205 shares of TWST for approximately $991,000 on May 29, 2026. — While insider selling can be a red flag, this specific trade was prearranged via a Rule 10b5-1 plan and represents a small fraction of his total holdings.
-0.10Ticker attribution
Model heads
Continue reading
6 related stories
The company reported strong revenue growth, raised full-year guidance, and is described as having excellent business performance.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
GlobeNewsWire
3h ago
